Rituximab is used in the treatment of
Correct Answer: Pemphigus
Description: Rituximab * Chimeric IgG monoclonal antibody targeting the B-cell surface antigen (CD20) * FDA approved for non-Hodgkin's lymphoma, chronic lymphocytic leukemia, and RA unresponsive to other treatments * Off-label dermatologic uses include bullous dermatoses (especially pemphigus vulgaris and severe bullous pemphigoid), autoimmune connective tissue diseases, chronic graft-versus-host disease, vasculitis, and cutaneous B-cell lymphoma * Depletion of B-cells occurs within 2 to 3 weeks of initial treatment with sustained depletion for an average of 6 months; B-cell numbers return to normal within the first year of treatment * Relative contraindication in patients with history of bronchospasm, hypotension, or angioedema * Pregnancy category C * Common adverse effects include: hypeension, nausea, upper respiratory tract infection, ahralgia, pyrexia, and pruritus; most common are infusion reactions, which are generally mild and occur with the first infusion # Patients with history of cardiac or pulmonary conditions should be more closely monitored as they are susceptible to severe infusion reactions * Serious SEs: HBV reactivation, progressive multifocal leukoencephalopathy SJS/TEN, serious infection, hepatic failure and myelosuppression. Ref:- Review of Dermatology by Alikhan pg num:-39,40
Category:
Dental
Get More
Subject Mock Tests
Practice with over 200,000 questions from various medical subjects and improve your knowledge.
Attempt a mock test nowMock Exam
Take an exam with 100 random questions selected from all subjects to test your knowledge.
Coming SoonGet More
Subject Mock Tests
Try practicing mock tests with over 200,000 questions from various medical subjects.
Attempt a mock test now